FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Dimethyl topics
Physiologic
Hydrochloric Acid
Fresnel Zone
Aberration
Ophthalmic
Liquid Crystal
Imaging System
Pharmaceutically Acceptable Salt
Pharmaceutically Acceptable Salts
Chloric Acid
Tartaric Acid
Fumaric Acid
Antagonist
Bradykinin
Enantiomer

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Dimethyl patents



      
           
This page is updated frequently with new Dimethyl-related patent applications. Subscribe to the Dimethyl RSS feed to automatically get the update: related Dimethyl RSS feeds. RSS updates for this page: Dimethyl RSS RSS


Enhanced oil recovery method

Enhanced oil recovery method

Date/App# patent app List of recent Dimethyl-related patents
12/11/14
20140364654
 Dimethyl ether (dme) production process patent thumbnailnew patent Dimethyl ether (dme) production process
Disclosed herein is a process for monetization of natural gas by producing fuel grade dimethyl ether (dme). The process includes three reactive stages with the first reactive stage being the conversion of natural gas into syngas, the second reactive stage being the conversion of syngas into crude methanol and the third reactive stage being the production of fuel grade dimethyl ether.
12/11/14
20140364651
 Method for synthesizing polyoxymethylene dimethyl ethers patent thumbnailnew patent Method for synthesizing polyoxymethylene dimethyl ethers
The present invention relates to the field of chemical engineering and technology, in particular relates to the sub-field of synthesis of high quality alternative liquid engine fuel from non-petroleum based feedstock, more particularly relates to a method for regulating and optimizing the synthetic process of polyoxymethylene dimethyl ethers utilizing chemical thermodynamic principle. The process of the present invention is achieved by conditions wherein the initial temperature of reaction is controlled at 100-120° c., then the temperature is reduced to 50-70° c.
12/11/14
20140364612
 Industrial process for the preparation of buprenorphine and its intermediates patent thumbnailnew patent Industrial process for the preparation of buprenorphine and its intermediates
There is provided an efficient industrial process for the preparation of 21-cyclopropyl-7α-(2-hydroxy-3,3-dimethyl-2-butyl)-6,14-endo-ethano-6,7,8,14-tetrahydro-oripavine, i.e. Buprenorphine of formula-i in high yield and purity, with enhanced safety and eco-friendly norms.
12/11/14
20140363717
 Low viscosity/high conductivity sodium haloaluminate electrolyte patent thumbnailnew patent Low viscosity/high conductivity sodium haloaluminate electrolyte
An additive that is added to the naalx4 electrolyte for use in a zebra battery (or other similar battery). This additive has a moiety with a partial positive charge (δ+) that attracts the negative charge of the [alx4]− moiety and weakens the ionic bond between the na+ and [alx4]− moieties, thereby freeing some na+ ions to transport (move).
12/11/14
20140362239
 Surface adhering lens patent thumbnailnew patent Surface adhering lens
A lens structure includes an elastomer formed as a lens. The lens has a planar surface and a curved surface opposed to the planar surface.
12/11/14
20140360727
 Remediation of asphaltene-induced plugging of an oil-bearing formation patent thumbnailnew patent Remediation of asphaltene-induced plugging of an oil-bearing formation
A system and method for remediation of asphaltene-induced fouling of an oil-bearing formation is provided wherein an asphaltene solvent comprising at least 75 mol % dimethyl sulfide is introduced into an oil-bearing formation containing asphaltene deposits and the dimethyl sulfide is contacted with the asphaltene deposits.. .
12/11/14
20140360719
 Enhanced oil recovery method patent thumbnailnew patent Enhanced oil recovery method
A method for producing oil from a fractured oil bearing formation is provided in which an oil recovery formulation comprising water and dimethyl ether is introduced into a fracture in the formation to mobilize oil, the mobilized oil is contacted with water or brine, and the mobilized oil is produced from the formation at a location positioned upwards from the fracture.. .
12/04/14
20140357901
 Systems and methods for recovering dimethyl ether from gas mixtures and liquid mixtures patent thumbnailSystems and methods for recovering dimethyl ether from gas mixtures and liquid mixtures
An apparatus includes an airtight shell and an absorption column arranged inside the shell. The absorption column has a multiple stage component, and a single stage component arranged below the multiple stage component with respect to gravity.
12/04/14
20140357831
 Method of making polybenzimidazole patent thumbnailMethod of making polybenzimidazole
A method of making a polybenzimidazole (pbi) includes the steps of: reacting, in a solution, an organic compound having at least 2 amino groups with an organic aldehyde adduct, the reactants comprise at least 8% by weight of the solution. A solvent of the solution may be selected from the group of: n,n-dimethylacetamide (dmac), n,n-dimethylformamide (dmf), dimethylsulfoxide (dmso), n-methyl-2-pyrrolidone (nmp), tetramethylene sulfone, and combinations thereof.
12/04/14
20140357762
 Use of n,n'-(dimethyl) urones and method for curing epoxy resin compositions patent thumbnailUse of n,n'-(dimethyl) urones and method for curing epoxy resin compositions
The invention relates to the use of bis- or multifunctional n,n′-(dimethyl) urons as curing agents for curing epoxy resin compositions in a controlled manner.. .
12/04/14
20140357754
Cement products and methods of making and using the same
Disclosed are cement products, methods of forming cement using the cement product, and methods of using the cement product in orthopedic and dental applications. Generally, the disclosed cement product includes a first component and a second component.
12/04/14
20140357729
Topical composition containing silicone base
It is an object to provide a topical composition that is excellent in texture and feeling upon use. The present invention is a topical composition without water, satisfying the following: (a) the composition includes a silicone base in a proportion of 80% by weight or more; (b) the silicone base includes (b1) a silicone elastomer, (b2) a cyclic volatile methylsiloxane having 3 to 6 silicon atoms, and (b3) a linear dimethylpolysiloxane and/or linear methylphenylpolysiloxane; (c) the composition includes therein an active ingredient present in a dispersed or dissolved type; and (d) the composition does not contain any non-silicone thickener..
12/04/14
20140357623
New enzyme inhibitor compounds
2-{4-[1-(4-chlorophenyl)-1h-pyrrolo[2,3-c]pyridin-3-yl]piperidin-1-yl}ethan-1-amine; 3-aminopropyl 4-[1-(4-chlorophenyl)-1h-pyrrolo[2,3-c]pyridin-3-yl]piperidine-1-carboxylate; 1-{4-[1-(4-chlorophenyl)-1h-pyrrolo[2,3-c]pyridin-3-yl]piperidin-1-yl}-4-(dimethylamino)butan-1-one; 5-amino-1-{4-[1-(4-chlorophenyl)-1h-pyrrolo[2,3-c]pyridin-3-yl]piperidin-1-yl}pentan-1-one; n-(2-aminoethyl)-4-[1-(4-chlorophenyl)-1h-pyrrolo[2,3-c]pyridin-3-yl]piperidine-1-carboxamide; n-(3-aminopropyl)-4-[1-(4-chlorophenyl)-1h-pyrrolo[2,3-c]pyridin-3-yl]piperidine-1-carboxamide; 4-[1-(4-chlorophenyl)-1h-pyrrolo[2,3-c]pyridin-3-yl]-n-[3-(dimethylamino)propyl]piperidine-1-carboxamide; 1-({4-[1-(4-chlorophenyl)-1h-pyrrolo[2,3-c]pyridin-3-yl]piperidin-1-yl}carbonyl)piperazine; 4-({4-[1-(4-chlorophenyl)-1h-pyrrolo[2,3-c]pyridin-3-yl]piperidin-1-yl}carbonyl)morpholine; 1-({4-[1-(4-chlorophenyl)-1h-pyrrolo[2,3-c]pyridin-3-yl]piperidin-1-yl}carbonyl)-1,4-diazepane; ethyl 1-[1-(4-chlorophenyl)-1h-pyrazolo[3,4-c]pyridin-3-yl]piperidine-4-carboxylate; ethyl 1-[1-(4-methylphenyl)-1h-pyrazolo[3,4-c]pyridin-3-yl]piperidine-4-carboxylate; 1-[1-(4-chlorophenyl)-1h-pyrazolo[3,4-c]pyridin-3-yl]piperidine-4-carboxylic acid; n-(2-aminoethyl)-1-[1-(4-chlorophenyl)-1h-pyrazolo[3,4-c]pyridin-3-yl]piperidine-4-carboxamide; 4-({1-[1-(4-chlorophenyl)-1h-pyrazolo[3,4-c]pyridin-3-yl]piperidin-4 yl}carbonyl)morpholine; 1-({1-[1-(4-chlorophenyl)-1h-pyrazolo[3,4-c]pyridin-3-yl]piperidin-4-yl}carbonyl)piperazine; {4-[1-(4-methylphenyl)-1h-pyrazolo[3,4-c]pyridin-3-yl]morpholin-3-yl}methanol; {4-[1-(4-methyl-phenyl)-1h-pyrazolo[3,4-c]pyridin-3-yl]morpholin-2-yl}methanol; [(3r)-4-[1-(4-chlorophenyl)-1h-pyrazolo[3,4-c]pyridin-3-yl]morpholin-3-yl]methanol; methyl 4-[1-(4-chlorophenyl)-1h-pyrazolo[3,4-c]pyridin-3-yl]morpholine-3-carboxylate; n-(2-aminoethyl)-4-[1-(4-chlorophenyl)-1h-pyrazolo[3,4-c]pyridin-3-yl]morpholine-3-carboxamide; 2-{4-[1-(4-chlorophenyl)-1h-pyrazolo[3,4-c]pyridin-3-yl]morpholin-3-yl}ethan-1-ol; methyl 1-[1-(4-chlorophenyl)-1h-pyrazolo[3,4-c]pyridin-3-yl]piperidine-2-carboxylate; n-(2-aminoethyl)-1-[1-(4-chlorophenyl)-1h-pyrazolo[3,4-c]pyridin-3-yl]piperidine-2-carboxamide; 1-({1-[1-(4-chlorophenyl)-1h-pyrazolo[3,4-c]pyridin-3-yl]piperidin-2-yl}carbonyl)piperazine; 4-[1-(4-methylphenyl)-1h-pyrrolo[2,3-c]pyridin-3-yl]morpholine; 1-(4-chlorophenyl)-3-(piperidin-4-yl)-1h-pyrrolo[2,3-c]pyridin-4-ol; n-butyl-1-(4-chlorophenyl)-n-methyl-1h-pyrazolo[3,4-c]pyridin-3-amine; 1-[4-(fluoromethyl)phenyl]-3-(oxan-4-yl)-1h-pyrazolo[3,4-c]pyridine; and 3-({4-[1-(4-chlorophenyl)-1h-pyrazolo[3,4-c]pyridin-3-yl]piperidin-1-yl}methyl)pyridine are useful for the inhibition of ssao activity.. .
12/04/14
20140357620
Method for administration of a gamma secretase inhibitor
There are provided a new dosage regimens for the gamma secretase inhibitor 2,2-dimethyl-n-((s)-6-oxo-6,7-dihydro-5h-dibenzo[b,d]azepin-7-yl)-n-(2,2,3,3,3-pentafluoro-propyl)-malonamide which maximizes anti-tumor activity while maintaining acceptable toxicity levels.. .
12/04/14
20140357489
Emulsifiable concentrate comprising pesticide, dimethyl sulfoxide, benzyl alcohol, alkyl lactate
Subject matter of the present invention is an emulsifiable concentrate comprising a water-insoluble pesticide, benzyl alcohol, alkyl lactate and not more than 40% by weight of dimethyl sulfoxide. A further subject matter is an emulsion obtainable by mixing water with the emulsifiable concentrate; a process for the preparation of the emulsifiable concentrate; and a method for controlling phytopathogenic fungi and/or undesired vegetation and/or undesired attack by insects or mites and/or for regulating the growth of plants, where the concentrate or the emulsion is allowed to act on the respective pests, their environment or on the crop plants to be protected from the respective pests, on the soil and/or on undesired plants and/or on the crop plants and/or their environment..
12/04/14
20140357091
Semiconductor fabrication process
Semiconductor fabrication processes are described. An embodiment of the semiconductor fabrication process includes providing a layer formed by decomposition of dimethylsilane through chemical vapor deposition, the layer being applied by a fluid material, and then positioning the layer in a system for producing a semiconductor product.
12/04/14
20140356975
Low temperature activator systems and methods for chemiluminescent reactions
In some embodiments, the instant invention provides a chemiluminescent system, including: an activator system, including: (a) at least one first solvent, (b) at least one peroxide, (c) at least one catalyst, (d) at least one second solvent, where the at least one second solvent is selected from the group consisting of: tert-butanol, 3-methyl-3-pentanol, 2-methyl-2-butanol, ethyl 2-hydroxyisobutyrate, methyl 2-hydroxyisobutyrate, ethylene glycol, propylene glycol, ethylene glycol monomethyl ether, ethylene glycol diethyl ether, ethylene glycol monobutyl ether, ethylene glycol dibutyl ether, propylene glycol dimethyl ether, and a combination thereof; where a combination of the at least one first solvent and the at least one second solvent is present in a sufficient amount in the chemiluminescent system so as to result in the chemiluminescent system producing a light having an illuminescence between 0.1 1× and 35,000 1× at a temperature ranging from −110 degrees celsius to 75 degrees celsius.. .
12/04/14
20140356314
3-[3-(dimethylamino)-1-ethyl-2-methylpropyl]phenol resin complex
The present invention discloses a 3-[3-(dimethylamino)-1-ethyl-2-methylpropyl]phenol resin complex, preferably an amorphous 3-[3-(dimethylamino)-1-ethyl-2-methylpropyl]phenol resin complex formed by the reaction between a cation exchange resin and 3-[3-(dimethylamino)-1-ethyl-2-methylpropyl]phenol or a pharmaceutically acceptable acid addition salt thereof. It can exhibit an in-vitro release rate of 3-[3-(dimethylamino)-1-ethyl-2-methylpropyl]phenol from the 3-[3-(dimethylamino)-1-ethyl-2-methylpropyl]phenol resin complex which is in accordance with the requirements of ph.
11/27/14
20140350302
(r)-6-(dimethylamino)-4,4-diphenylheptan-3-one
(r)-6-(dimethylamino)-4,4-diphenylheptan-3-one and a process to produce thereof.. .
11/27/14
20140350294
Methods of producing para-xylene and terephthalic acid
The present disclosure provides methods to produce para-xylene, toluene, and other compounds from renewable sources (e.g., cellulose, hemicellulose) and ethylene in the presence of an acid, such as a lewis acid. For example, cellulose and/or hemicellulose may be converted into 2,5-dimethylfuran (dmf) and 2-methylfuran, which may be converted into para-xylene and toluene, respectively.
11/27/14
20140350283
Compounds and methods for preparing substituted 3-(1-amino-2-methylpentane-3-yl)phenyl compounds
Compounds and methods for preparing substituted 3-(1-amino-2-methylpentane-3-yl)phenyl compounds from an isomerically pure starting material are described. In particular, methods of preparing a 3-(1-(dimethylamino)-2-methylpentane-3-yl)phenol as a substantially optically pure (r,r) stereoisomer are described.
11/27/14
20140350039
Combination
The present invention relates to a method of treating cancer in a human and to pharmaceutical combinations useful in such treatment. In particular, the method relates to a cancer treatment method that includes administering n-{3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide or a pharmaceutically acceptable salt thereof, and n-{(1s)-2-amino-1-[(3,4-difluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)-2-furancarboxamide, or a pharmaceutically acceptable salt thereof, to a human in need thereof..
11/27/14
20140348728
Method for improving gold recovery
Disclosed are methods and compositions for improving metal extraction processes by introducing at least one cationically charged compound selected from a group consisting of amines, particularly quaternary amines such as alkyldimethylbenzylammonium chlorides (adbac compounds), polyamines and other suitable cationic organic materials, and mixtures thereof, for neutralizing and/or coagulating excess anionic organic compounds including, for example, flotation reagents, surfactants, polymers, flotation reagent by-products and/or anti-scalant additives found in metal concentrate streams, and thereby reduce the downstream fouling of the activated carbon by these compounds.. .
11/20/14
20140343339
Method for obtaining olefins from furnace gases of steel works
The invention relates to a method for processing furnace gas (4) from a steel and/or iron works, wherein said furnace gas (4) contains carbon dioxide and/or carbon monoxide and is at least partially integrated into a method (7) for the formation of dimethyl ether in conjunction with a hydrogen-containing gas (2), whereby a dme-containing product gas (8) is formed. At the outset of the method (7) for forming dimethyl ether, a ratio of hydrogen to carbon monoxide, weighted with the carbon dioxide concentration (formula (i)), of 0.9 to 1.1 is set and dimethyl ether is formed.
11/20/14
20140343337
Catalyst for producing paraxylene by co-conversion of methanol and/or dimethyl ether and c4 liquefied gas, method for preparing the same and method for using the same
This application provides a catalyst for producing paraxylene by co-conversion of methanol and/or dimethyl ether and c4 liquefied gas, and preparation and application thereof. The catalyst is an aromatization molecular sieve catalyst with a shape-selective function co-modified by bimetal and siloxane compound.
11/20/14
20140343290
Process for the preparation of atazanavir or its bisulfate salt
The present invention relates to an improved process for the preparation of atazanavir bisulfate, an inhibitor of retroviral aspartate protease. The process of the present invention comprises conversion of 1,1-dimethylethyl[(2s,3r)-4-chloro-3-hydroxy-phenylbutan-2-yl]carbamate (formula ii) into 1-[4-(pyridine-2-yl)-phenyl]-4(s)-5 hydroxy-2-n-tert-butoxycarbonylamino-5(s)—n—(n-methoxycarbonyl-(l)-tert-leucyl)amino-6-phenyl-2-azahexane (formula vii) without isolating intermediate compounds formed therein, followed by its subsequent conversion to atazanavir or its bisulfate salt..
11/20/14
20140343287
Process for the manufacture of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]-piperazine
A process for the manufacture of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]-piperazine and pharmaceutically acceptable salts is disclosed that involves reacting compounds of formula ii, iii, iv under pd catalysis and in presence of phosphine ligands to give compound i.. .
11/20/14
20140343275
Process for the preparation of drospirenone
It is described of a process for the preparation of drospirenone, the compound of formula 1 shown below, a synthetic steroid with progestogenic, antimineralocorticoid and antiandrogenic activity, useful for preparing pharmaceutical compositions having contraceptive action, starting from 17α-(3-hydroxypropyl)-6β,7β;15β,16β-dimethylene-5β-androstane-3β,5,17β-trioi.. .
11/20/14
20140343141
Topical composition comprising an ingenol derivative and a surfactant-cosolvent mixture
A topical composition for cutaneous application which is a water-in-oil emulsion comprises an oily phase comprising (a) an ingenol derivative in dissolved form; (b) at least one non-ionic surfactant selected from the group consisting of polyoxyl glycerides, polyoxyethylene castor oil derivatives, polyoxyethylene alkyl ethers, polysorbates, or a mixture of acrylamide acryloyldimethyl taurate copolymer, isohexadecane and polysorbate 80, sterols, fatty alcohols, fatty acid phosphonates, mono- or diglycol esters, mono- di- or polyglyceryl esters, mono-, di- or plyglucose esters, sucrose esters or sorbitan esters, the non-ionic surfactant being present in an amount of from about 0.5% by weight to about 10% by weight of the composition; (c) a solvent for the ingenol derivative; and an aqueous phase buffered to a ph of 2.6-3.7.. .
11/20/14
20140342039
Polysiloxane (silicone) treatment composition for suppression of mold and spoilage on animal feed and forage, and method of using same
Polydimethylsiloxane and/or siloxane (silicone)-derived chemical compounds are used to coating harvested forages to protect against rain and/or other weather damage and to suppress mold and spoilage in harvested forages. The pdms compound and derivatives thereof are also found to suppress the damage resulting from oxidation within the feedstuff mass.
11/20/14
20140341991
3'-[(2z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
Disclosed are novel pharmaceutical compositions containing 3′-[(2z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine) (eltrombopag olamine) and processes for preparing the same.. .
11/20/14
20140341818
Solubilized magnolol analogs
A composition comprising a solubilized magnolol analog comprising at least one magnolol analog chosen from propyl magnolol, isopropyl magnolol, butyl magnolol, and isobutyl magnolol, and dimethyl isosorbide. These solubilized analogs are useful in personal care, oral care, and home care compositions to provide anti-bacterial activity and reducing the expression of pro-inflammatory mediators..
11/20/14
20140339475
Alkaline earth metal co-precipitated nickel-based catalyst for steam carbon dioxide reforming of natural gas
Disclosed is a catalyst used for steam carbon dioxide reforming of natural gas, wherein an alkaline earth metal alone or an alkaline earth metal and a group 8b metal are supported on a hydrotalcite-like catalyst containing nickel, magnesium and aluminum. The disclosed catalyst is useful as a steam carbon dioxide reforming (scr) catalyst of natural gas at high temperature and high pressure, while minimizing deactivation of the catalyst due to sintering of the active component nickel and deactivation of the catalyst due to coke generation at the same time.
11/20/14
20140339456
Refractory castables with hydrophobic aggregates
Hydrophobic aggregates for use in refractory castables and gunning mixtures and methods of their preparation. The aggregates here are formed by crushing insulating fire brick and coating the resulting particles with a hydrophobic component.
11/20/14
20140338904
Systems and method for separating dimethyl ether from oil and water
A system is provided for removing dimethyl ether (dme) from oil, water or brine and gas that includes a gas-oil-water separation module, a dme absorber, a water stripper, a liquid-liquid extractor, a water source, and an oil stripper, and a process is provided for separating dme from a mixture of dme, crude oil, water or brine, and a gas containing alkane hydrocarbons. A dme lean oil containing at most 1 ppmwt may be produced by the process..
11/13/14
20140336420
System and method for producing gasoline or dimethyl ether
A system or method for producing gasoline or dimethyl ether from natural gas via methanol includes: steam-reforming natural gas to generate reformed gas; synthesizing methanol from the reformed gas; synthesizing gasoline or dimethyl ether from the methanol; and at least one is selected from the group consisting of: pre-reforming natural gas prior to the steam-reforming; recovering carbon dioxide from flue gas generated in the steam-reforming; and preheating combustion air to be supplied to the steam-reforming by using synthesis heat generated in the synthesis of gasoline or dimethyl ether. In addition, an overall energy balance of the system is constructed by using heat recovery from flue gas generated in the steam-reforming, heat recovery from the reformed gas, synthesis heat generated in the synthesis of methanol, synthesis heat generated in the synthesis of gasoline or dme, and heat recovered in the pre-reforming, carbon dioxide recovering, or air preheating, respectively if selected..
11/06/14
20140330043
Hexafluorodimethylcarbinol terminated alkane- and alkenethiols
A hexafluorodimethylcarbinol terminated compound, method of making it, and a composition of matter are disclosed. The compound may have the formula (cf3)2c(oh)-l-m-r.
11/06/14
20140329855
Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
The present invention relates to solid state forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (compound 1), pharmaceutical compositions thereof and methods therewith.. .
11/06/14
20140328784
Hair conditioning cosmetic compositions containing a mixture of amidoamines
Compositions are provided and described herein which include cosmetic and hair conditioning compositions having a mixture of stearamidopropyl dimethylamine and behenamidopropyl dimethylamine. Also provided are methods for conditioning hair using such mixtures..
11/06/14
20140328783
Cosmetic composition comprising a supramolecular compound capable of establishing hydrogen bonds, and two particular distinct silicone oils
The present invention relates to a cosmetic composition comprising, in a cosmetically acceptable medium, at least: (a) a supramolecular compound that may be obtained by reaction between: —at least one oil bearing at least one nucleophilic reactive function chosen from oh and nh2, and —at least one junction group capable of establishing hydrogen bonds with one or more partner junction groups, each pairing of a junction group involving at least three hydrogen bonds, the said junction group bearing at least one isocyanate or imidazole reactive function capable of reacting with the reactive function borne by the oil, the said junction group also comprising at least one unit of formula (i) or (ii): (b) at least two distinct non-volatile silicone oils chosen from: i) phenyl silicone oils, in particular of formula (ii) or (vii) below: ii) linear or cyclic polydimethylsiloxanes (pdmss), iii) polydimethylsiloxanes comprising alkyl or alkoxy groups, which are pendent and/or at the end of the silicone chain, these groups each containing from 2 to 24 carbon atoms, and (d) at least one agent for structuring the liquid fatty phase.. .
11/06/14
20140325839
Dimethyl ether (dme) enhanced gasoline engine
An engine having dme pilot ignition is disclosed. Dme pilot ignition creates far more energy than a conventional spark plug, thus minimizes the possibility of misfire in the engine map.
10/30/14
20140323591
Water-based skin cosmetic
(b) a thickener composed of microgel obtained by using a composition that has an organic solvent or oil component as the dispersion medium and water as the dispersion phase, dissolving a water soluble ethylenically unsaturated monomer in the dispersion phase, and radically polymerizing it in the dispersion phase, wherein said microgel is obtained by radically polymerizing dimethylacrylamide and 2-acrylamido-2 methylpropane sulfonic acid under the conditions in which a single phase microemulsion or fine w/o emulsion is formed by using a surfactant.. .
10/30/14
20140323570
Neuroprotection in demyelinating diseases
Methods of treating neurological disorders characterized by extensive demyelination and/or axonal loss are provided. Examples of such disorders include secondary progressive multiple sclerosis and devic's disease.
10/30/14
20140323539
Emulsifiable concentrate comprising pesticide, dimethyl sulfoxide, benzyl alcohol, alkyl lactate and diester
Where r1 is c1-c8-alkyl and r2 is c2-c10-alkanediyl or c2-c10-alkenediyl. A further subject matter is an emulsion obtainable by mixing water with the emulsifiable concentrate; a process for the preparation of the emulsifiable concentrate; and a method for controlling phytopathogenic fungi and/or undesired vegetation and/or undesired attack by insects or mites and/or for regulating the growth of plants, where the concentrate or the emulsion is allowed to act on the respective pests, their environment or on the crop plants to be protected from the respective pests, on the soil and/or on undesired plants and/or on the crop plants and/or their environment..
10/30/14
20140323521
Pharmaceutical compositions and administrations thereof
The present invention relates to the use of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide, solids forms, and pharmaceutical compositions thereof for the treatment of cftr mediated diseases, particularly cystic fibrosis, in patients possessing specific genetic mutations.. .
10/30/14
20140323506
Combination
The present invention relates to a method of treating cancer in a human and to pharmaceutical combinations useful in such treatment. In particular, the method relates to a cancer treatment method that includes administering 5-[[4-[(2,3-dimethyl-2h-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide, or a pharmaceutically acceptable salt thereof, and n-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo-phenylamino)6,8-dimethy;-2,4,7-trioxo-3,4,6,7-tetrahydro-2h-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide, or a pharmaceutically acceptable salt or solvate thereof, to a human in need thereof..
10/30/14
20140323387
5,5-dimethyl-2-propyl-hexahydro-2,4a-methano-naphthalen-1-one as a fragrance agent
As well as a composition comprising at least said compound of general formula (i), and its uses in perfumery.. .
10/30/14
20140322810
Natural and synthetic compounds for treating cancer and other diseases
This invention provides a method of synthesizing new active compounds for pharmaceutical uses including cancer treatment, wherein the cancers comprise breast, leukocytic, liver, ovarian, bladder, prostatic, skin, bone, brain, leukemia, lung, colon, cns, melanoma, renal, cervical, esophageal, testicular, spleenic, kidney, lymphatic, pancreatic, stomach and thyroid cancers. This invention is an anti-adhesion therapy which uses the compound as a mediator or inhibitor of adhesion proteins and angiopoietins.
10/30/14
20140322576
Lithium ion battery
A high-input and high-output battery having a large capacity while guaranteeing safety is provided. As a composition of an electrolytic solution, a composition ratio of ethylene carbonate (ec) is 20 vol % or more and 30 vol % or less, and a composition ratio of dimethyl carbonate (dmc) is 36 vol % or more and 50 vol % or less, and a composition ratio η (dmc/emc) of dimethyl carbonate (dmc) and ethyl methyl carbonate (emc) is 1.05≦η≦1.7.
10/30/14
20140319423
Sulfolane mixtures as ambient aprotic polar solvents
An improved solvent containing sulfolane and at least one dialkyl sulfone, preferably dimethyl sulfone, wherein the improved solvent is a liquid at room temperature and can be used for reaction media and electrochemistry.. .
10/23/14
20140316155
Methyl-substituted biphenyl compounds, their production and their use in the manufacture of plasticizers
In a process for producing methyl-substituted biphenyl compounds, a feed comprising at least one aromatic hydrocarbon selected from the group consisting of toluene, xylene and mixtures thereof is contacted with hydrogen in the presence of a hydroalkylation catalyst under conditions effective to produce a hydroalkylation reaction product comprising (methylcyclohexyl)toluenes and/or (dimethylcyclohexyl)xylenes together with dialkylated c21+ compounds. At least part of the dialkylated c21+ compounds is then removed from the hydroalkylation reaction product to produce a dehydrogenation feed; and at least part of the dehydrogenation feed is dehydrogenated in the presence of a dehydrogenation catalyst under conditions effective to produce a dehydrogenation reaction product comprising a mixture of methyl-substituted biphenyl compounds..
10/23/14
20140316004
Treatment of poultry for reducing the feed conversion rate or for reducing the incidence of ascites
Wherein r1 and r2 are independently an alkyl, an alkenyl or a hydroxyalkyl radical containing 1 to 18, preferably 1 to 6 carbon atoms or wherein r1 and r2 form jointly together with the n atom a heterocyclic 5- or 6-membered ring. The glycine compound is preferably n,n-dimethylglycine (dmg).
10/23/14
20140315948
Pharmaceutical composition and administrations thereof
The present invention relates to pharmaceutical compositions comprising a solid dispersion of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide, methods of manufacturing pharmaceutical compositions of the present invention, and methods of administering pharmaceutical compositions of the present invention.. .
10/23/14
20140315921
1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairment
This disclosure relates to 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine or a pharmaceutically acceptable salt thereof in a crystalline form.. .
10/23/14
20140315127
Single component developer composition
Emulsion aggregation toner comprising: a resin; a wax; a colorant; an encapsulating shell; and a silica external additive comprising: first silica particles comprising fumed silica particles surface treated with octyldimethylsiloxane and having average particle diameter about 6-20 nm, present in amount of about 0.1-1% by weight of the toner; second silica particles comprising colloidal silica particles surface treated with hexamethyldisiloxane and having average particle diameter about 80-200 nm, present in amount of about 1-2% by weight of the toner; third silica particles comprising fumed silica particles surface treated with polydimethylsiloxane and having average particle diameter about 25-65 nm, present in amount of from about 0.5-1.5% by weight of the toner; and fourth silica particles comprising fumed silica particles surface treated with hexamethyldisiloxane and having average particle diameter about 25-65 nm, present in amount of about 1-2.5% by weight of the toner.. .
10/23/14
20140315119
Highly conductive anion-exchange composite membrane with crosslinked polymer electrolyte for alkaline fuel cell and method for preparing the same
Disclosed are a new method for preparing a highly conductive anion-exchange composite membrane with a crosslinked polymer electrolyte for an alkaline fuel cell and a composite membrane prepared by the same. The method includes (a) mixing (vinylbenzyl)trimethylammonium chloride, 1,3,5-triacryloylhexahydro-1,3,5-triazine, and a mixed solution of deionized water and dimethyl formamide at a weight ratio of 1:1 together by stirring at a weight ratio of 60˜75:5˜16:20˜25; (b) mixing 100 parts by weight of the mixed solution with 0.5 to 2 parts by weight of a photoinitiator; (c) impregnating a porous polymer support with the solution so that a monomer solution soaks into the support; (d) interposing an electrolyte-impregnated membrane between polyethylene terephthalate (pet) films and irradiating the electrolyte-impregnated membrane with ultraviolet (uv) light having an energy of 30 to 150 mj/cm2 for crosslinking; and (e) after the crosslinking step, removing the pet films, and removing by-products on the membrane surface and washing the membrane..


Popular terms: [SEARCH]

Dimethyl topics: Physiologic, Hydrochloric Acid, Fresnel Zone, Aberration, Ophthalmic, Liquid Crystal, Imaging System, Pharmaceutically Acceptable Salt, Pharmaceutically Acceptable Salts, Chloric Acid, Tartaric Acid, Fumaric Acid, Antagonist, Bradykinin, Enantiomer

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Dimethyl for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Dimethyl with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         



Key IP Translations - Patent Translations



0.4427

3279

1 - 1 - 72